Calvin Chao

Calvin Chao is a seasoned executive in the field of medical affairs with extensive experience in leadership roles across various healthcare companies. Currently serving as the Senior Vice President of Medical Affairs at Tempus Labs, Inc. since March 2021, Calvin Chao previously held significant positions including Vice President of Global Medical Affairs and Vice President of International Medical Affairs at Genomic Health where responsibilities included overseeing medical affairs for multiple molecular diagnostic products. Earlier experience includes roles at Onyx Pharmaceuticals, PDL BioPharma, TAP Pharmaceutical Products, CIGNA HealthCare, and PulseMD, contributing to pharmaceutical launches, medical management, and strategic support. Calvin Chao holds an MBA from The Wharton School, an MD from The University of Texas Medical Branch, and a BS in Chemical Engineering from the University of California, Berkeley.